IRadimed
IRMD
#5616
Rank
A$1.87 B
Marketcap
A$147.44
Share price
-0.70%
Change (1 day)
62.94%
Change (1 year)
Categories

Earnings for IRadimed (IRMD)

Earnings in 2025 (TTM): A$41.9 Million

According to IRadimed's latest financial reports the company's current earnings are A$80.51 Million. In 2024 the company made an earning of A$36.31 Million, an increase over its 2023 earnings that were of A$32.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IRadimed from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$41.9 M15.38%
2024 A$36.31 M11.67%
2023 A$32.52 M34.35%
2022 A$24.2 M64.5%
2021 A$14.71 M-1694.53%
2020 -A$0.93 Million-106.82%
2019 A$13.52 M45.92%
2018 A$9.27 M343.81%
2017 A$2.08 M-87.25%
2016 A$16.38 M-5.86%
2015 A$17.4 M285.59%
2014 A$4.51 M8.39%
2013 A$4.16 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AtriCure
ATRC
-A$32.92 Million-181.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NuVasive
NUVA
A$91.14 M 126.36%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.46 B 3,533.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$2.55 B 6,242.24%๐Ÿ‡บ๐Ÿ‡ธ USA